Table 4. Incidence of drug-related adverse events in sorafenib group.
| Adverse event | Toxicity grade | |||
|---|---|---|---|---|
| 1 | 2 | 3 | 4 | |
| Hypertension | 1 | 1 | 0 | 0 |
| Agrypnia | 1 | 0 | 0 | 0 |
| Hand–foot skin reaction | 3 | 1 | 1 | 0 |
| Diarrhea | 2 | 1 | 0 | 0 |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.